Question 1

What are the potential side effects of alemtuzumab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT clinical trial (NCT03368664). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to my current medications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT clinical trial (NCT03368664). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the treatment schedule look like, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT clinical trial (NCT03368664). Contact the study team or your healthcare provider for specific answers.

Question 4

What should I do if I experience any side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT clinical trial (NCT03368664). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my progress be monitored during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT clinical trial (NCT03368664). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I decide to stop participating in the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT clinical trial (NCT03368664). Contact the study team or your healthcare provider for specific answers.

What this study is about